Protective effect of infliximab on ischemia/reperfusion-induced damage in rat kidney

Renal Failure

Volumn 34, Issue 9, 2012, Pages 1144-1149

  Tasdemir, Cemal ^a   Tasdemir, Seda ^a   Vardi, Nigar ^b   Ates, Burhan ^a   Parlakpinar, Hakan ^a   Kati, Bulent ^a   Karaaslan, Merve Goksin ^a   Acet, Ahmet ^a  

^a INONU UNIVERSITY   (Turkey)

^b Medical Faculty   (Turkey)

Author keywords

Infliximab; Ischemiareperfusion; Renal

Indexed keywords

GLUTATHIONE; INFLIXIMAB; MALONALDEHYDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME BLOOD LEVEL; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; KIDNEY; KIDNEY TUBULES; MALE; MALONDIALDEHYDE; PEROXIDASE; RATS; RATS, WISTAR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866401335     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.717490     Document Type: Article

References (37)

1. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003; 14(8):2199-2210.
2. Akçetin Z, Busch A, Kessler G, et al. Evidence for only a moderate lipid peroxidation during ischemia-reperfusion of rat kidney due to its high antioxidative capacity. Urol Res. 1999; 27(4):280-284.
3. Defraigne JO, Detry O, Pincemail J, et al. Direct evidence of free radical production after ischemia and reperfusion and protective effect of desferrioxamine: ESR. and vitamin E studies. Eur J Vasc Surg. 1994;8(5):537-543.
4. Paller MS. Acute renal failure: Controversies, clinical trials, and future directions. Semin Nephrol. 1998;18(5):482-489.
5. Weinberg JM. The cell biology of ischemic renal injury. Kidney Int. 1991;39(3):476-500.
6. Erdogan H, Fadillioglu E, Emre MH. Protection from renal ischemia reperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production. Toxicology. 2006;228(2-3):219-228.
7. Serteser M, Koken T, Kahraman A, et al. Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res. 2002;107(2):234-240.
8. Sener G, Sehirli O, Velioǧlu-Oǧünç A, et al. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res. 2006;54(1):65-71.
9. Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, Corazza GR. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Pharmacol Ther. 2004; 19(9):1019-1024.
10. Savastano M, Marioni G, Giacomelli L, et al. Sensorineural hearing loss in ankylosing spondylitis treated with TNFblockers. B-ENT. 2010;6(3):183-188.
11. Wildhirt SM, Weismueller S, Schulze C, et al. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: Evidence for a late phase of nitric oxidemediated reperfusion injury. Cardiovasc Res. 1999;43(3): 698-711.
12. Cash D, Beech JS, Rayne RC, et al. Neuroprotective effect of aminoguanidine on transient focal ischemia in the rat brain. Brain Res. 2001;905(1-2):91-103.
13. Vermeulen NP, Baldew GS. The role of lipid peroxidation in the nephrotoxicity of cisplatin. Biochem Pharmacol. 1992; 44(6):1193-1199.
14. Guven C, Borcek AO, Cemil B, et al. Neuroprotective effects of infliximab in experimental spinal cord ischemic injury. J Clin Neurosci. 2010;17(12):1563-1567.
15. Gonder JC, Laber K. A renewed look at laboratory rodent housing and management. ILAR J. 2007;48(1):29-36.
16. Tasdemir S, Parlakpinar H, Vardi N, Kaya E, Acet A. Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis. Fundam Clin Pharmacol. 2011.
17. Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol. 1978;52:302-310.
18. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods. 1990;24(4):285-295.
19. Tok A, Sener E, Albayrak A, et al. Effect of mirtazapine on oxidative stress created in rat kidneys by ischemia-reperfusion. Ren Fail. 2012;34(1):103-110.
20. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244(22):6049-6055.
21. Liu F, Lou Y-L, Wu J, et al. Upregulation of MicroRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res. 2011;35(3):182-191.
22. Sehirli AO, Sener G, Satiroglu H, Ayanoǧlu-Dülger G. Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol. 2003;16(1):75-80.
23. Walker LM, York JL, Imam SZ, et al. Oxidative stress and reactive nitrogen species generation during renal ischemia. Toxicol Sci. 2001;63(1):143-148.
24. Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281(5):F948-F957.
25. Atilgan D, Parlaktas BS, Uluocak N, et al. Effects of melatonin on partial unilateral ureteral obstruction induced oxidative injury in rat kidney. Urol Ann. 2012;4(2):89-93.
26. Elmas O, Elmas O, Caliskan S. Investigation of the oxidative effect of chronic hyperammonemia on the kidney and the possible protective effect of allopurinol. Ren Fail. 2011;33(1):61-65.
27. Takahashi M. Oxidative stress and redox regulation on in vitro development of mammalian embryos. J Reprod Dev. 2012;58(1):1-9.
28. Korkmaz A, Kolankaya D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J Surg Res. 2010;164(2):309-315.
29. Unal D, Yeni E, Erel O, Bitiren M, Vural H. Antioxidative effects of exogenous nitric oxide versus antioxidant vitamins on renal ischemia reperfusion injury. Urol Res. 2002;30(3): 190-194.
30. Xu Y, Liu M, Peng B, et al. Protective effects of SP600125 on renal ischemia-reperfusion injury in rats. J Surg Res. 2011;169(1): E77-e84.
31. Sahna E, Parlakpinar H, Ozturk F, Cigremis Y, Acet A. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res. 2003;31(3):188-193.
32. Wieland E, Brandes A, Armstrong VW, Oellerich M. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes. Eur J Clin Chem Clin Biochem. 1993; 31(11):725-731.
33. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994;94(1):437-444.
34. Watanabe M, de Moura Neiva LB, da Costa Santos CX, Martins Laurindo FR, de Fátima Fernandes Vattimo M. Isoflavone and the heme oxygenase system in ischemic acute kidney injury in rats. Food Chem Toxicol. 2007;45(12):2366- 2371.
35. Sekhon CS, Sekhon BK, Singh I, Orak JK, Singh AK. Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy. J Nephrol. 2003;16(1):63-74.
36. Elliott MJ, Maini RN, Feldmann M, et al. Randomised doubleblind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994;344(8930):1105-1110.
37. Kurt G, Ergün E, Cemil B, et al. Neuroprotective effects of infliximab in experimental spinal cord injury. Surg Neurol. 2009;71(3):332-336, discussion 336.